CN101704791B - Method for synthesizing 1H,3H-quinazoline-2,4-diketone - Google Patents

Method for synthesizing 1H,3H-quinazoline-2,4-diketone Download PDF

Info

Publication number
CN101704791B
CN101704791B CN2009102374234A CN200910237423A CN101704791B CN 101704791 B CN101704791 B CN 101704791B CN 2009102374234 A CN2009102374234 A CN 2009102374234A CN 200910237423 A CN200910237423 A CN 200910237423A CN 101704791 B CN101704791 B CN 101704791B
Authority
CN
China
Prior art keywords
formula
quinazoline
diketone
chloride
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102374234A
Other languages
Chinese (zh)
Other versions
CN101704791A (en
Inventor
李加荣
陈霰
李英
马淑玲
李青
史大昕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Institute of Technology BIT
Original Assignee
Beijing Institute of Technology BIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Institute of Technology BIT filed Critical Beijing Institute of Technology BIT
Priority to CN2009102374234A priority Critical patent/CN101704791B/en
Publication of CN101704791A publication Critical patent/CN101704791A/en
Application granted granted Critical
Publication of CN101704791B publication Critical patent/CN101704791B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a method for synthesizing 1H,3H-quinazoline-2,4-diketone, belonging to the filed of organic synthesis. The method comprises the following steps: taking o-amino-nitrile as raw materials, catalyzing the raw materials by Lewis acid and protonic acid, condensing the raw materials with N-alkyl formamide, and synthesizing the 1H,3H-quinazoline-2,4-diketone and derivative thereof by one step. The method avoids the use of cyanide (toxic) in the traditional method, and simultaneously improves the productivity to a greater extent.

Description

A kind of synthetic 1H, 3H-quinazoline-2, the method for 4-diketone
Technical field
The present invention relates to a kind of synthetic 1H, 3H-quinazoline-2, (4-diones) method of compound belongs to the synthetic field of medicine to the 4-diketone for English name 1H, 3H-quinazoline-2.
Background technology
1H, 3H-quinazoline-2,4-diketone heterocyclic compounds has good biological activity and pharmaceutical activity, is one type of important medicine and fine-chemical intermediate; Can be used for the synthetic of various medicines, as via 1H, 3H-quinazoline-2; The 4-diketone can synthesize N-phenyl lungy-1H-quinazoline-2 that strong anti-mycobacterium is active, the treatment mycobacterium causes, 4-cyclohexadione compounds (Farmaco, 2001; 56:803-807), the mother of synthetic a series of PDE-4 of having (phosphodiesterase IN) selective depressant encircles material 3-N-ethyl-1-N-(2-nitro)-phenyl-1H, 3H-quinazoline-2; 4-diketone (Eur.J.Med.Chem, 2000,35 (5): 4632-480); Via 7-chloro-1H, 3H-quinazoline-2, the synthetic FK366 of 4-diketone with reductase inhibitor and diabetic complication, And be used to treat cardiotropic formulation KF31327 (Tetrahedron, 2002,58:3155), and 6,7-dimethoxy-1H, 3H-quinazoline-2,4-diketone can be used for synthetic α 1-adrenergic receptor blocker medicine Prazosin (Minipress), Bunazosin (Detantol) and Doxazosin (Cardenalin) (Tetrahedron Letter; 2004,45:7073), Alfuzosin (J.Med.Chem.1986; 29:19-25.), IAAP (J.Org.Chem.2002; 67 (23): 8284-8286.) and Vasocard (Chinese Journal of Pharmaceuticals, 2000,31 (9): 385); 1H, 3H-quinazoline-2,4-cyclohexadione compounds also can be used for 8-hydroxyl-1-(the 3-N-morpholinyl)-n-propyl-1H of synthetic ADP ribose polymerase suppressor factor; 3H-quinazoline-2,4-diketone, 8-hydroxyl-1-(3-phenoxy)-n-propyl-1H; 3H-quinazoline-2; 4-diketone (Biochimica et Biophysica Acta, 2006,17 (4): 913-919); In addition, 1H, 3H-quinazoline-2,4-diketone also can be used for synthetic agricultural chemicals SYP-298 (ZL00123348.3,2000-11-30 with higher weeding activity and crop safety; Modern agricultural chemicals, 2004,3 (6): 14) etc.
Known 1H, 3H-quinazoline-2, the compound method of 4-dione compounds mainly contains: 1) with fennel acid and urea reaction make (Pharmazie, 1982,37:115-117); 2) with anthranilamide photoreactive gas reaction make (Org.Prep.Proced.Int., 1978,10:13-16); 3) react with Potssium Cyanide with fennel acid and make (Org.Synth., 1943,2:79-80); 4) react with the chlorosulfonyl phenylcarbimide with fennel acid and make (Tetrahedron, 1994,50:6549-6558); 5) with the reaction of the phenylcarbimide of 2-anthranilo nitrile and equivalent again with acid hydrolysis make (J.Amer.Chem.Soc., 1961,27:2622-2627); 6) with 2-anthranilo nitrile and verivate and CO 2Under excess catalyst catalysis be with DMF solvent reaction 24 hours (Tetrahedron, 2002,58:3155-3158) or solvent-free high pressure use postcritical CO down 2(scCO 2) reaction 4 hours (Tetrahedron Letter, 2004,45:7073-7075) make; 7) with facing anthranilo nitrile and DMF in sealed vessel, ZnCl 2Cyclisation under the catalytic condition (Org.Lett., 2009,11 (6): 1193-1196.) make.All there is deficiency in these compound methods, and are high like reagent costliness or toxicity, reaction conditions is too violent, operational hazards, productive rate are too low etc.
In sum, the price of these methods or reagent is too expensive, toxicity is high, the perhaps too violent operational hazards of reaction conditions, and perhaps complicated operation, perhaps productive rate is too low, and these deficiencies all have inconvenience for their synthetic particularly industrial production.
Summary of the invention
The objective of the invention is in order to solve the synthetic 1H of tradition, 3H-quinazoline-2, the method complicated operation of 4-diketone, productive rate are low; Problems such as reagent costs an arm and a leg, toxicity is big; Synthesize 1H and propose a kind of the reaction, 3H-quinazoline-2, the method for 4-diketone with adjacent amino fragrant nitrile and N-alkyl formamides.
The objective of the invention is to realize through following technical scheme.
A kind of synthetic 1H of the present invention; 3H-quinazoline-2; The method of 4-diketone, its concrete steps are: with the amino fragrant nitrile of neighbour, Lewis catalyzer, acid or alkali, N-alkyl formamides, solvent is 1: 0.1~5: 0.2~0.5: 2: 10~20 ratio in molar ratio, adds in the autoclave respectively; Temperature of reaction is more than 190 ℃, and the reaction times is 1~5 hour.After reaction finished, placement was cooled to room temperature and uses distilled water diluting, separates out white precipitate, filtration, recrystallization, and obtaining white crystal is 1H, 3H-quinazoline-2,4-diketone.
Its reaction expression is:
Figure G2009102374234D00021
Wherein, the amino fragrant nitrile structure of described neighbour is shown below:
Figure G2009102374234D00031
In the formula, R 1, R 2, R 3, R 4Be H, F, Cl, Br, I, alkyl, alkoxyl group, nitro, 4,5-OCH 2O-, four methynes.R 5Be H, alkyl, phenyl.
Described N-alkyl formamides structure is shown below:
Figure G2009102374234D00032
In the formula, R 6, R 7Be all methyl or be all ethyl.
Described N-alkyl formamides be following any one: N (DMF) or DEF.
Said solvent be following any one: benzene,toluene,xylene, oil of mirbane, chlorobenzene, tetramethylene sulfone, DMSO, N (DMF) or DEF etc.
Said Lewis catalyzer be following any one: zinc chloride, aluminum chloride, cupric chloride, cuprous chloride, toluene sulfonic acide, p-methyl benzenesulfonic acid, mercury chloride, cuprous chloride, titanium tetrachloride, tin chloride etc.
Described acid be following any one: HCl, H 2SO 4, H 3PO 4, acetic acid, (CH 2) 3-SO 3H,
Figure G2009102374234D00033
Described alkali be following any one: sodium methylate, sodium ethylate, pyridine, ammoniacal liquor, NaOH, KOH, Na 2CO 3, NaHCO 3, K 2CO 3, KHCO 3
Beneficial effect:
The present invention uses adjacent nitrile compound to be reaction substrate, process and DMF condensation, and single step reaction can obtain 1H, 3H-quinazoline-2,4-diketone and verivate thereof.Use Lewis acid and the common catalysis of protonic acid, avoided using the prussiate that relates in the traditional method, reduce injury, reduced pollution environment to operator; Productive rate improves a lot simultaneously, reduces cost and has improved production efficiency.
Specific embodiment
Embodiment 1
The 2-anthranilo nitrile (0.3g, 0.002mol), DMF (8.0mL), Zinc Chloride Anhydrous (0.27g, 0.002mol), mixed solution join in the autoclave, drip the 0.1ml concentrated hydrochloric acid, oil bath is heated with stirring to 190 ℃ of reactions 5 hours.Stop heating, reaction finishes, and places and is cooled to room temperature.With the reaction solution dilute with water, separate out white precipitate.Suction filtration, water washing.Use 1 again, 4-dioxane thermosol, filtered while hot is removed insoluble impurity then.Gained filtrating is carried out vacuum rotary steam, obtains light yellow solid, uses the mixed solvent recrystallization of methyl alcohol and THF then, and productive rate is 95%, m.p.>300 ℃.The structural characterization data of reaction formula and product thereof are as follows:
Figure G2009102374234D00041
The structural characterization data of product:
IR(KBr),σ/cm -1:3302,3055,1701,1682,1617,1444,1300,1142,757
1H?NMR(400MHz,DMSO)δ:11.3(s,1H,-CO-NH-CO-),11.2(s,1H,Ar-NH-CO-),7.91(d,1H,ArH),7.65(d,1H,ArH),6.94(m,2H,ArH)
MS(m/z):163(M+H +)
Ultimate analysis: calcd.C 59.25H 3.70N 17.28; Found C 58.89H 3.71N17.17.
Embodiment 2
The 2-anthranilo nitrile (0.59g, 0.005mol), DMF (8.0mL), Zinc Chloride Anhydrous (0.67g, 0.005mol), mixed solution join in the autoclave, add 0.04gCH again 3ONa, oil bath is heated with stirring to 190 ℃ of reactions 5 hours.Stop heating, reaction finishes, and places and is cooled to room temperature.With the reaction solution dilute with water, separate out white precipitate.Suction filtration, water washing.Use 1 again, 4-dioxane thermosol, filtered while hot is removed insoluble impurity then.Gained filtrating is carried out vacuum rotary steam, obtains light yellow solid, uses the mixed solvent recrystallization of methyl alcohol and THF then, and productive rate is 93%, m.p.>300 ℃.
Embodiment 3
The 2-anthranilo nitrile (0.59g, 0.005mol), DMF (8.0mL), anhydrous cupric chloride (0.67g, 0.005mol), mixed solution join in the autoclave, drip the 0.1ml concentrated hydrochloric acid, oil bath is heated with stirring to 190 ℃ of reactions 5 hours.Stop heating, reaction finishes, and places and is cooled to room temperature.With the reaction solution dilute with water, separate out white precipitate.Suction filtration, water washing.Use 1 again, 4-dioxane thermosol, filtered while hot is removed insoluble impurity then.Gained filtrating is carried out vacuum rotary steam, obtains light yellow solid, uses the mixed solvent recrystallization of methyl alcohol and THF then, and productive rate is 78%, m.p.>300 ℃.

Claims (1)

1. one kind is synthesized suc as formula the 1H shown in 1; 3H-quinazoline-2; The method of 4-diketone is characterized in that concrete steps are: with the amino fragrant nitrile of neighbour, Lewis catalyzer, acid or alkali, N-alkyl formamides, solvent is 1: 0.1~5: 0.2~0.5: 2: 10~20 ratio in molar ratio, adds in the autoclave respectively; Temperature of reaction is more than 190 ℃, and the reaction times is 1~5 hour; After reaction finished, placement was cooled to room temperature and uses distilled water diluting, separates out white precipitate, filtration, recrystallization, and obtaining white crystal is the 1H shown in the formula 1,3H-quinazoline-2,4-diketone;
Wherein, the amino fragrant nitrile structure of described neighbour is suc as formula shown in 2:
Figure FDA0000112431770000011
Formula 1 formula 2
In the formula, R 1, R 2, R 3, R 4Be H, F, Cl, Br, I, alkyl, alkoxyl group, nitro; R 5Be H;
Described N-alkyl formamides structure is shown below:
Figure FDA0000112431770000012
In the formula, R 6, R 7Be all methyl or be all ethyl;
Said solvent be following any one: benzene,toluene,xylene, oil of mirbane, chlorobenzene, tetramethylene sulfone, DMSO, DMF or DEF;
Said Lewis catalyzer be following any one: zinc chloride, aluminum chloride, cupric chloride, cuprous chloride, mercury chloride, titanium tetrachloride, tin chloride;
Described acid is HCl; Described alkali is sodium methylate.
CN2009102374234A 2009-11-06 2009-11-06 Method for synthesizing 1H,3H-quinazoline-2,4-diketone Expired - Fee Related CN101704791B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102374234A CN101704791B (en) 2009-11-06 2009-11-06 Method for synthesizing 1H,3H-quinazoline-2,4-diketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102374234A CN101704791B (en) 2009-11-06 2009-11-06 Method for synthesizing 1H,3H-quinazoline-2,4-diketone

Publications (2)

Publication Number Publication Date
CN101704791A CN101704791A (en) 2010-05-12
CN101704791B true CN101704791B (en) 2012-06-20

Family

ID=42375055

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102374234A Expired - Fee Related CN101704791B (en) 2009-11-06 2009-11-06 Method for synthesizing 1H,3H-quinazoline-2,4-diketone

Country Status (1)

Country Link
CN (1) CN101704791B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101096360A (en) * 2006-10-10 2008-01-02 北京理工大学 Method for synthesizing 1H,3H-quinazoline-2,4-diketone compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101096360A (en) * 2006-10-10 2008-01-02 北京理工大学 Method for synthesizing 1H,3H-quinazoline-2,4-diketone compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Li Jiarong, et al..A New and Facile Synthesis of Quinazoline-2,4(1H,3H)-diones.《ORAGANIC LETTERS》.2009,第11卷(第6期),1193-1196. *
LiJiarong et al..A New and Facile Synthesis of Quinazoline-2

Also Published As

Publication number Publication date
CN101704791A (en) 2010-05-12

Similar Documents

Publication Publication Date Title
CN109053625B (en) Preparation method of substituted benzothiazole C2 alkylated derivative
US20100267949A1 (en) Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline
CN108033922B (en) Preparation method of 3-acyl quinoxalinone derivative
CN104447686B (en) Polysubstituted 2-pyrroles's pyridine derivate and preparation method thereof
CN103601686A (en) Method for synthesizing fluorine-containing pyrimidine compounds by virtue of one-pot method
CN101020658A (en) Synthesis process of main cyclic quinoline compound
CN114315823B (en) Intermediate of berberine hydrochloride and analogues thereof and preparation method thereof
CN102001979B (en) Preparation method of 2-(2', 2'-difluoroethoxyl)-6-trifluoromethyl phenyl propyl sulfide
CN104311485B (en) A kind of preparation method treating leukemic medicine bosutinib
CN101704791B (en) Method for synthesizing 1H,3H-quinazoline-2,4-diketone
CN103694182B (en) A kind of preparation method of quinoxaline compound
CN101096360A (en) Method for synthesizing 1H,3H-quinazoline-2,4-diketone compound
CN110256451B (en) Synthetic method of benzofuro [2,3-b ] quinoline derivative
CN106336378A (en) Method for preparing quinoline-2-formic acid ester series substances
CN107954960B (en) Synthetic method of 1,3-dihydroisobenzofuran compound
CN104016927B (en) Pyrimidine mercaptoacetamide derivative and preparation method thereof and application
JPH0782268A (en) Production of benzothiadiazole derivative
CN107915748B (en) Preparation method of 4- (tert-butyl) -1-phenyl-imidazo [4,5,1-kl ] phenoxazine
CN113214162A (en) Preparation method of benzimidazole derivative
CN108409648B (en) Preparation method of sorafenib tosylate related intermediate
CN101555248B (en) Method for preparing poly-substituted 1, 5-naphthyridine compound
CN110606839A (en) Green synthesis method of polysubstituted quinazoline derivative
CN109400507A (en) The synthesis of Ailamode intermediate impurities
KR101554539B1 (en) Development of Method for Amide Bond Formation via Metal-Free Aerobic Oxidative Amination of Aldehydes
CN102718694A (en) 3-cyan substituted indole compound and synthetic method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120620

Termination date: 20121106